Structural Revision of Baulamycin A and Structure-Activity Relationships of Baulamycin A Derivatives

Sandip Sengupta, Munhyung Bae, Dong Chan Oh, Uttam Dash, Hak Joong Kim, Woon Young Song, Injae Shin, Taebo Sim

Research output: Contribution to journalArticlepeer-review

9 Citations (Scopus)

Abstract

Total synthesis of the proposed structure of baulamycin A was performed. The spectral properties of the synthetic compound differ from those reported for the natural product. On the basis of comprehensive NMR study, we proposed two other possible structures for natural baulamycin A. Total syntheses of these two substances were performed, which enabled assignment of the correct structure of baulamycin A. Key features of the convergent and fully stereocontrolled route include Evans Aldol and Brown allylation reactions to construct the left fragment, a prolinol amide-derived alkylation/desymmetrization to install the methyl-substituted centers in the right fragment, and finally, a Carreira alkynylation to join both fragments. In addition, we have determined the inhibitory activities of novel baulamycin A derivatives against the enzyme SbnE. This SAR study provides useful insight into the design of novel SbnE inhibitors that overcome the drug resistance of pathogens, which cause life-threatening infections.

Original languageEnglish
Pages (from-to)12947-12966
Number of pages20
JournalJournal of Organic Chemistry
Volume82
Issue number24
DOIs
Publication statusPublished - 2017 Dec 15

Bibliographical note

Funding Information:
This work was supported by the Korea Institute of Science and Technology, the KU-KIST Graduate School of Converging Science and Technology Program, and KRF (Korea Research Fellowship) program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science and ICT (NRF-2015R1D1A1A01056815).

Publisher Copyright:
© 2017 American Chemical Society.

ASJC Scopus subject areas

  • Organic Chemistry

Fingerprint

Dive into the research topics of 'Structural Revision of Baulamycin A and Structure-Activity Relationships of Baulamycin A Derivatives'. Together they form a unique fingerprint.

Cite this